Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 479 7133
Email
greg.walker@otago.ac.nz
Position
Associate Professor Head of the Bayer Centre for Dairy Animal Health / Pharmaceutical Science and Product Innovations at the School of Pharmacy (2019-present)
Qualifications
BSc MSc PhD(Otago)
Research summary
Drug delivery and formulation
Teaching
  • PHCY211: Fundamental Pharmaceutical Sciences (Dosage forms module coordinator)
  • PHCY220: Integrated modules A
  • PHCY430: Elective Projects B
  • PHCY485: Honours
Memberships
  • Controlled Release Society (2012-present)
  • New Zealand Chapter of the Controlled Release Society (2012 to present): President of the Society (November 2017 to present)

Research

Associate Professor Walker’s general area of research interest is in formulation and delivery of bioactive molecules. Particular interests are in physico-chemical principles relating to how delivery systems can influence the absorption, disposition and fate of bioactives in the body and how such systems can increase the efficacy of bioactives.

He has extensive experience in polymeric drug delivery systems, engineering formulations for biopharmaceuticals, project management and pre-clinical studies.

Prior to joining University of Otago as a lecturer, he was the Research and Development Manager at a UK biotech company where he invented the lead technology of a new class of topical haemostat (PeproStat) which has completed successful phase two clinical trials.

As head of the Bayer Centre for Dairy Animal Health / Pharmaceutical Science and Product Innovations at the School of Pharmacy, he applies his formulation and drug delivery expertise to issues relating to veterinary and animal health.

Associate Professor Walker is a key researcher in three Ministry of Business, Innovation and Employment (MBIE) grants totalling to over NZ $19 million. These projects focus on the formulation and delivery of: vaccines, a new class of antimicrobials and bioactives to crops.

PhD projects are available, please contact me if you are interested in conducting PhD research in the field of formulation and drug delivery.

Publications

Shah, R. M., Reily-Bell, M., Katare, R., Walker, G., & Das, S. (2023). Development and evaluation of microRNA-134 encapsulated cationic liposomes for chronic obstructive pulmonary disease. Pharmacy Education, 23(6), (pp. 149). doi: 10.46542/pe.2023.236.129157 Conference Contribution - Published proceedings: Abstract

Shah, R. M., Lyu, A., Walker, G. F., Katare, R., & Das, S. C. (2023). Inhaled ceftazidime dry powder developed using spray freeze drying technique. Proceedings of the 34th Drug Delivery to the Lungs (DDL) Conference. 34, (pp. 320-323). Retrieved from https://ddl-conference.com Conference Contribution - Published proceedings: Full paper

Shah, R., Walker, G., Katare, R., & Das, S. (2022, November). Spray-freeze drying: An emerging technique for producing inhalable microparticles of thermosensitive bioactives. Verbal presentation at the School of Pharmacy Research Day, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Shah, R. M., Katare, R., Walker, G., & Das, S. C. (2022, November). Physicochemical characterization of exosome-mimetic nanoparticles for chronic obstructive pulmonary disease. Poster session presented at the New Zealand Controlled Release Society (NZCRS) Symposium, Auckland, New Zealand. Conference Contribution - Poster Presentation (not in published proceedings)

Nguyen, H. V., Campbell, K., Painter, G. F., Young, S. L., & Walker, G. F. (2022, November). Intratumoral delivery of immune-therapeutics: Effect of carrier molecular weight on the in vitro immune-stimulatory activity of the CpG-dextran conjugates. Verbal presentation at the New Zealand Controlled Release Society (NZCRS) Symposium, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Back to top